Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study
Richard MA Follows, Neil G Snowise, Shu-Yen Ho, Claire L Ambery…Том:
14
Мова:
english
DOI:
10.1186/1465-9921-14-54
Date:
December, 2013
Файл:
PDF, 364 KB
english, 2013
File converter
Більше результатів пошуку
More benefits 
